207 related articles for article (PubMed ID: 35731254)
1. Diversity of the bacteriocins, their classification and potential applications in combat of antibiotic resistant and clinically relevant pathogens.
Choi GH; Holzapfel WH; Todorov SD
Crit Rev Microbiol; 2023 Sep; 49(5):578-597. PubMed ID: 35731254
[TBL] [Abstract][Full Text] [Related]
2. Bacteriocin-Based Synergetic Consortia: a Promising Strategy to Enhance Antimicrobial Activity and Broaden the Spectrum of Inhibition.
Soltani S; Biron E; Ben Said L; Subirade M; Fliss I
Microbiol Spectr; 2022 Feb; 10(1):e0040621. PubMed ID: 35170996
[TBL] [Abstract][Full Text] [Related]
3. Bacteriocins from lactic acid bacteria as an alternative to antibiotics.
Ołdak A; Zielińska D
Postepy Hig Med Dosw (Online); 2017 May; 71(0):328-338. PubMed ID: 28513457
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in bacteriocin application as antimicrobials.
Gillor O; Ghazaryan L
Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):115-22. PubMed ID: 18221167
[TBL] [Abstract][Full Text] [Related]
5. Synergy between novel antimicrobials and conventional antibiotics or bacteriocins.
Wolska KI; Grześ K; Kurek A
Pol J Microbiol; 2012; 61(2):95-104. PubMed ID: 23163208
[TBL] [Abstract][Full Text] [Related]
6. Lactic acid bacteria and their bacteriocins: new potential weapons in the fight against methicillin-resistant
Yaacob SN; Wahab RA; Misson M; Sabullah MK; Huyop F; Zin NM
Future Microbiol; 2022 Jun; 17():683-699. PubMed ID: 35414206
[TBL] [Abstract][Full Text] [Related]
7. Gram-positive bacteriocins: usage as antimicrobial agents in veterinary medicine.
Schofs L; Sparo MD; Sánchez Bruni SF
Vet Res Commun; 2020 Nov; 44(3-4):89-100. PubMed ID: 32656740
[TBL] [Abstract][Full Text] [Related]
8. Bacteriocins: Potential for Human Health.
Huang F; Teng K; Liu Y; Cao Y; Wang T; Ma C; Zhang J; Zhong J
Oxid Med Cell Longev; 2021; 2021():5518825. PubMed ID: 33936381
[TBL] [Abstract][Full Text] [Related]
9. Bacteriocins from lactic acid bacteria and their potential clinical applications.
Fernandes A; Jobby R
Appl Biochem Biotechnol; 2022 Oct; 194(10):4377-4399. PubMed ID: 35290605
[TBL] [Abstract][Full Text] [Related]
10. Nisin resistance in Gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use.
Barbosa AAT; de Melo MR; da Silva CMR; Jain S; Dolabella SS
Crit Rev Microbiol; 2021 May; 47(3):376-385. PubMed ID: 33689548
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
Chi H; Holo H
Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
[TBL] [Abstract][Full Text] [Related]
12. Structural Features, Mechanisms of Action, and Prospects for Practical Application of Class II Bacteriocins.
Antoshina DV; Balandin SV; Ovchinnikova TV
Biochemistry (Mosc); 2022 Nov; 87(11):1387-1403. PubMed ID: 36509729
[TBL] [Abstract][Full Text] [Related]
13. [Bacteriocins produced by lactic acid bacteria].
Bilková A; Sepova HK; Bilka F; Balázová A
Ceska Slov Farm; 2011 Apr; 60(2):65-72. PubMed ID: 21650008
[TBL] [Abstract][Full Text] [Related]
14. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
Heselpoth RD; Euler CW; Schuch R; Fischetti VA
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered bacteriocins and their potential as the next generation of antimicrobials.
Gillor O; Nigro LM; Riley MA
Curr Pharm Des; 2005; 11(8):1067-75. PubMed ID: 15777256
[TBL] [Abstract][Full Text] [Related]
16. Are bacteriocins underexploited? Novel applications for old antimicrobials.
Montalbán-López M; Sánchez-Hidalgo M; Valdivia E; Martínez-Bueno M; Maqueda M
Curr Pharm Biotechnol; 2011 Aug; 12(8):1205-20. PubMed ID: 21470151
[TBL] [Abstract][Full Text] [Related]
17. Novel enterocin E20c purified from Enterococcus hirae 20c synergised with ß-lactams and ciprofloxacin against Salmonella enterica.
Sharma P; Rashid M; Kaur S
Microb Cell Fact; 2020 May; 19(1):98. PubMed ID: 32366243
[TBL] [Abstract][Full Text] [Related]
18. Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections.
Ghodhbane H; Elaidi S; Sabatier JM; Achour S; Benhmida J; Regaya I
Infect Disord Drug Targets; 2015; 15(1):2-12. PubMed ID: 24853876
[TBL] [Abstract][Full Text] [Related]
19. Combined Action of Antibiotics and Bacteriocins against Vancomycin-Resistant Enterococci.
Bucheli JEV; Fugaban JII; Holzapfel WH; Todorov SD
Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889141
[TBL] [Abstract][Full Text] [Related]
20. Loss of β-Ketoacyl Acyl Carrier Protein Synthase III Activity Restores Multidrug-Resistant Escherichia coli Sensitivity to Previously Ineffective Antibiotics.
Hong Y; Qin J; Verderosa AD; Hawas S; Zhang B; Blaskovich MAT; Cronan JE; Totsika M
mSphere; 2022 Jun; 7(3):e0011722. PubMed ID: 35574679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
